These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 27854147)

  • 1. Improving the developability of an anti-EphA2 single-chain variable fragment for nanoparticle targeting.
    Geddie ML; Kohli N; Kirpotin DB; Razlog M; Jiao Y; Kornaga T; Rennard R; Xu L; Schoerberl B; Marks JD; Drummond DC; Lugovskoy AA
    MAbs; 2017 Jan; 9(1):58-67. PubMed ID: 27854147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive optimization of a single-chain variable domain antibody fragment as a targeting ligand for a cytotoxic nanoparticle.
    Zhang K; Geddie ML; Kohli N; Kornaga T; Kirpotin DB; Jiao Y; Rennard R; Drummond DC; Nielsen UB; Xu L; Lugovskoy AA
    MAbs; 2015; 7(1):42-52. PubMed ID: 25484041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production and characterization of a novel site-specific-modifiable anti-OX40-receptor single-chain variable fragment for targeted drug delivery.
    Tanabe A; Nakano K; Nakakido M; Nagatoishi S; Tanaka Y; Tsumoto K; Uchimaru K; Watanabe T
    Biochem Biophys Res Commun; 2018 Feb; 496(2):614-620. PubMed ID: 29330050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stability engineering of anti-EGFR scFv antibodies by rational design of a lambda-to-kappa swap of the VL framework using a structure-guided approach.
    Lehmann A; Wixted JH; Shapovalov MV; Roder H; Dunbrack RL; Robinson MK
    MAbs; 2015; 7(6):1058-71. PubMed ID: 26337947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative study of the developability of full-length antibodies, fragments, and bispecific formats reveals higher stability risks for engineered constructs.
    Condado-Morales I; Dingfelder F; Waibel I; Turnbull OM; Patel B; Cao Z; Rose Bjelke J; Nedergaard Grell S; Bennet A; Hummer AM; Raybould MIJ; Deane CM; Egebjerg T; Lorenzen N; Arosio P
    MAbs; 2024; 16(1):2403156. PubMed ID: 39364796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PET-Guided Evaluation and Optimization of Internalized Antibody-Drug Conjugates Targeting Erythropoietin-Producing Hepatoma A2 Receptor.
    Jacobson O; Li Q; Chen H; Niu G; Kiesewetter DO; Xu L; Cook K; Yang G; Dall'Acqua W; Tsui P; Peng L; Chen X
    J Nucl Med; 2017 Nov; 58(11):1838-1844. PubMed ID: 28546337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of disulfide-stabilized Fabs for targeting of antibody-directed nanotherapeutics.
    Geddie ML; Kirpotin DB; Kohli N; Kornaga T; Boll B; Razlog M; Drummond DC; Lugovskoy AA
    MAbs; 2022; 14(1):2083466. PubMed ID: 35708974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel synthetic trivalent single chain variable fragment (tri-scFv) construction platform based on the SpyTag/SpyCatcher protein ligase system.
    Alam MK; Brabant M; Viswas RS; Barreto K; Fonge H; Ronald Geyer C
    BMC Biotechnol; 2018 Sep; 18(1):55. PubMed ID: 30200951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of therapeutic antibody self-association using yeast-display selections and machine learning.
    Makowski EK; Chen H; Lambert M; Bennett EM; Eschmann NS; Zhang Y; Zupancic JM; Desai AA; Smith MD; Lou W; Fernando A; Tully T; Gallo CJ; Lin L; Tessier PM
    MAbs; 2022; 14(1):2146629. PubMed ID: 36433737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Engineering Antibodies with C-Terminal Sortase-Mediated Modification for Targeted Nanomedicine.
    Hashad RA; Lange JL; Tan NCW; Alt K; Hagemeyer CE
    Methods Mol Biol; 2019; 2033():67-80. PubMed ID: 31332748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single chain anti-c-Met antibody conjugated nanoparticles for in vivo tumor-targeted imaging and drug delivery.
    Lu RM; Chang YL; Chen MS; Wu HC
    Biomaterials; 2011 Apr; 32(12):3265-74. PubMed ID: 21306768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific binding of the pathogenic prion isoform: development and characterization of a humanized single-chain variable antibody fragment.
    Skrlj N; Vranac T; Popović M; Curin Šerbec V; Dolinar M
    PLoS One; 2011 Jan; 6(1):e15783. PubMed ID: 21283753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and biodistribution of genetically-engineered antibodies.
    Colcher D; Pavlinkova G; Beresford G; Booth BJ; Choudhury A; Batra SK
    Q J Nucl Med; 1998 Dec; 42(4):225-41. PubMed ID: 9973838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Humanization of a highly stable single-chain antibody by structure-based antigen-binding site grafting.
    Villani ME; Morea V; Consalvi V; Chiaraluce R; Desiderio A; Benvenuto E; Donini M
    Mol Immunol; 2008 May; 45(9):2474-85. PubMed ID: 18313757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvement of anti-Burkholderia mouse monoclonal antibody from various phage-displayed single-chain antibody libraries.
    Kim HS; Lo SC; Wear DJ; Stojadinovic A; Weina PJ; Izadjoo MJ
    J Immunol Methods; 2011 Sep; 372(1-2):146-61. PubMed ID: 21787781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancing recombinant antibody performance by optimally engineering its format.
    Murphy C; Stack E; Krivelo S; Breheny M; Ma H; O'Kennedy R
    J Immunol Methods; 2018 Dec; 463():127-133. PubMed ID: 30321550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel disulfide-stabilized single-chain variable antibody fragment against rabies virus G protein with enhanced in vivo neutralizing potency.
    Duan Y; Gu TJ; Jiang CL; Yuan RS; Zhang HF; Hou HJ; Yu XH; Chen Y; Zhang Y; Wu YG; Kong W
    Mol Immunol; 2012 Jun; 51(2):188-96. PubMed ID: 22484084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved soluble expression of a single-chain antibody fragment in E. coli for targeting CA125 in epithelial ovarian cancer.
    Sharma SK; Suresh MR; Wuest FR
    Protein Expr Purif; 2014 Oct; 102():27-37. PubMed ID: 25079010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A strategy to identify linker-based modules for the allosteric regulation of antibody-antigen binding affinities of different scFvs.
    Kellmann SJ; Dübel S; Thie H
    MAbs; 2017 Apr; 9(3):404-418. PubMed ID: 28055297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two-step in vitro antibody affinity maturation enables estradiol-17beta assays with more than 10-fold higher sensitivity.
    Kobayashi N; Oyama H; Kato Y; Goto J; Söderlind E; Borrebaeck CA
    Anal Chem; 2010 Feb; 82(3):1027-38. PubMed ID: 20047279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.